This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Peroxisome proliferator-activated receptor 3D structures
From Proteopedia
(Difference between revisions)
| Line 10: | Line 10: | ||
**[[4bcr]], [[5hyk]] - hPPARα + ligand<br /> | **[[4bcr]], [[5hyk]] - hPPARα + ligand<br /> | ||
**[[1kkq]] – hPPARα + GW6471 Antagonist + SMRT<br /> | **[[1kkq]] – hPPARα + GW6471 Antagonist + SMRT<br /> | ||
| - | **[[2npa]] - hPPARα + propanoic acid derivative + NCOA1<br /> | ||
**[[2p54]] - hPPARα + NCOA1<br /> | **[[2p54]] - hPPARα + NCOA1<br /> | ||
**[[2rew]] - hPPARα + azetidinone derivative activator<br /> | **[[2rew]] - hPPARα + azetidinone derivative activator<br /> | ||
| Line 17: | Line 16: | ||
**[[3sp6]] - hPPARα + hPPARγ peptide + agonist<br /> | **[[3sp6]] - hPPARα + hPPARγ peptide + agonist<br /> | ||
**[[6kxx]], [[6kxy]] - hPPARα + peptide + agonist<br /> | **[[6kxx]], [[6kxy]] - hPPARα + peptide + agonist<br /> | ||
| - | **[[3et1]] - hPPARα + NCOA1 + indole derivative | + | **[[7c6q]] - hPPARα + peptide + sanguinarine<br /> |
| + | **[[3et1]] - hPPARα + NCOA1 + indole derivative<br /> | ||
| + | **[[6kb7]], [[6kba]] - hPPARα + pyrimidine derivative<br /> | ||
| + | **[[7e5f]], [[7e5g]], [[7e5h]], [[7e5i]] - hPPARα + propanoic acid derivative<br /> | ||
| + | **[[2npa]] - hPPARα + propanoic acid derivative + NCOA1 | ||
| + | **[[6jey]], [[6kax]], [[6kay]], [[6kaz]] ,[[6kb0]], [[6kb1]], [[6kb2]], [[6kb3]], [[6kb4]] ,[[6kb5]], [[6kb6]] ,[[6kb8]], [[6kb9]], [[6lx4]], [[6lx5]], [[6lx6]], [[6lx7]], [[6lx8]], [[6lx9]], [[6lxa]], [[6lxb]], [[6lxc]] - hPPARα + ampiphatic carboxylic acid derivative<br /> | ||
| + | **[[7bpy]], [[7bpz]], [[7bq0]], [[7bq1]], [[7bq2]], [[7bq3]], [[7bq4]] - hPPARα + NCOA1 + ampiphatic carboxylic acid derivative<br /> | ||
| + | **[[6l38]] - hPPARα + benzamide derivative<br /> | ||
| + | **[[6kyp]], [[6l36]], [[6l37]] - hPPARα + benzamide derivative + propanoic acid derivative <br /> | ||
| + | **[[5azt]] - hPPARα (mutant) + NCOA1 peptide<br /> | ||
*'''PPARγ''';Ligand-binding domain 202-475 | *'''PPARγ''';Ligand-binding domain 202-475 | ||
| - | **[[3prg]], [[2qmv]], [[1prg]], [[6l8b]] – hPPARγ<br /> | + | **[[3prg]], [[2qmv]], [[1prg]], [[6l8b]], [[6vzo]] – hPPARγ<br /> |
| - | **[[6fzy]], [[6fzg]] - hPPARγ (mutant) <br /> | + | **[[6fzy]], [[6fzg]], [[6t1s]], [[6vzn]], [[7cxe]] - hPPARγ (mutant) <br /> |
| - | **[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]] – hPPARγ + ligand <br /> | + | **[[2zk0]], [[2zk1]], [[2zk2]], [[2zk3]], [[2zk4]], [[2zk5]], [[2zk6]], [[3vjh]], [[3vji]], [[4e4k]], [[4e4q]], [[4jl4]], [[5hzc]], [[4ci5]], [[4ci4]], [[6an1]], [[2f4b]], [[1zeo]], [[2ath]], [[2hwq]], [[2hwr]], [[2i4j]], [[2q59]], [[2q8s]], [[3b3k]], [[3bc5]], [[3cds]], [[3g9e]], [[3gbk]], [[3gz9]], [[3ia6]], [[3kdt]], [[3an3]], [[3an4]], [[3noa]], [[3r5n]], [[3r8a]], [[3vso]], [[3vsp]], [[2xkw]], [[3b0q]], [[3ho0]], [[3hod]], [[1knu]], [[1i7i]], [[1nyx]], [[2pob]], [[5azv]], [[6f2l]], [[6c5t]], [[6c5q]], [[5wr1]], [[5wr0]], [[5wqx]], [[6md2]], [[6md4]], [[6md1]], [[6md0]], [[6mcz]], [[6k0t]], [[6avi]], [[6aug]], [[6qj5]], [[6t9c]], [[6tdc]], [[6vzl]], [[7lot]], [[7jqg]] – hPPARγ + ligand <br /> |
**[[4l98]], [[4l96]] - hPPARγ (mutant) + ligand<br /> | **[[4l98]], [[4l96]] - hPPARγ (mutant) + ligand<br /> | ||
**[[3r8i]] - hPPARγ + ureidofibrate derivative<br /> | **[[3r8i]] - hPPARγ + ureidofibrate derivative<br /> | ||
| Line 31: | Line 39: | ||
**[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ + antagonist<br /> | **[[3b0r]], [[5lsg]], [[4r6s]], [[4r2u]], [[4r06]], [[6dh9]], [[6dcu]], [[6dbh]] - hPPARγ + antagonist<br /> | ||
**[[3osi]], [[3osw]], [[3pba]] - hPPARγ + bisphenol derivative<br /> | **[[3osi]], [[3osw]], [[3pba]] - hPPARγ + bisphenol derivative<br /> | ||
| - | **[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]] - hPPARγ + modulator<br /> | + | **[[2p4y]], [[3adt]], [[3adu]], [[3adw]], [[3et3]], [[2hfp]], [[3ty0]], [[5two]], [[6fzj]], [[6t6b]], [[6y3u]], [[7a7h]] - hPPARγ + modulator<br /> |
**[[2zvt]] - hPPARγ (mutant) + modulator<br /> | **[[2zvt]] - hPPARγ (mutant) + modulator<br /> | ||
**[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]] - hPPARγ + fatty acid activator<br /> | **[[2vsr]], [[2vst]], [[2vv0]], [[2vv1]], [[2vv2]], [[2vv3]], [[2vv4]], [[3x1i]], [[3x1h]], [[3wj5]], [[3wj4]], [[3po9]], [[3sz1]] - hPPARγ + fatty acid activator<br /> | ||
**[[6jey]] - hPPARγ + fatty acid<br /> | **[[6jey]] - hPPARγ + fatty acid<br /> | ||
| - | **[[6jf0]] - hPPARγ + fluorescent probe<br /> | + | **[[6jf0]], [[7efq]] - hPPARγ + fluorescent probe<br /> |
**[[6mcz]], [[6md0]], [[6md1]], [[6md2]], [[6qj5]], [[6t9c]] - hPPARγ + ligand<br /> | **[[6mcz]], [[6md0]], [[6md1]], [[6md2]], [[6qj5]], [[6t9c]] - hPPARγ + ligand<br /> | ||
**[[6tsg]] - hPPARγ + hormone<br /> | **[[6tsg]] - hPPARγ + hormone<br /> | ||
| - | **[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]], [[6o67]], [[6o68]] - hPPARγ + anti-inflammatory drug<br /> | + | **[[3ads]], [[3adx]], [[5u5l]], [[4xum]], [[4xuh]], [[4xta]], [[4xld]], [[6d5a]], [[6o67]], [[6o68]], [[7ahj]], [[7awc]], [[7awd]], [[7e0a]] - hPPARγ + anti-inflammatory drug<br /> |
**[[4oj4]] - hPPARγ (mutant) + anti-inflammatory drug<br /> | **[[4oj4]] - hPPARγ (mutant) + anti-inflammatory drug<br /> | ||
**[[3adv]] - hPPARγ + serotonin<br /> | **[[3adv]] - hPPARγ + serotonin<br /> | ||
**[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ + antidiabetic drug<br /> | **[[3k8s]], [[3et0]], [[2yfe]], [[4a4v]], [[4a4w]], [[4jaz]], [[5tto]], [[4pwl]], [[4pvu]], [[5y2t]], [[5y2o]], [[5ugm]], [[6dha]] - hPPARγ + antidiabetic drug<br /> | ||
| - | **[[4o8f]] - hPPARγ (mutant) + antidiabetic drug<br /> | + | **[[4o8f]], [[6vzm]] - hPPARγ (mutant) + antidiabetic drug<br /> |
**[[6md4]] - hPPARγ + oleic acid + antidiabetic drug<br /> | **[[6md4]] - hPPARγ + oleic acid + antidiabetic drug<br /> | ||
**[[6enq]] - hPPARγ + antifibrotic drug<br /> | **[[6enq]] - hPPARγ + antifibrotic drug<br /> | ||
| + | **[[6zly]] - hPPARγ + valine derivative <br /> | ||
*PPARγ complex with polypeptide | *PPARγ complex with polypeptide | ||
| Line 51: | Line 60: | ||
**[[5dwl]], [[5dvc]], [[5dv8]], [[5dv6]], [[5dv3]], [[5dsh]] - hPPARγ + NCOA2 peptide + inhibitor<br /> | **[[5dwl]], [[5dvc]], [[5dv8]], [[5dv6]], [[5dv3]], [[5dsh]] - hPPARγ + NCOA2 peptide + inhibitor<br /> | ||
**[[1zgy]] – hPPARγ + antidiabetic drug + nuclear receptor peptide<br /> | **[[1zgy]] – hPPARγ + antidiabetic drug + nuclear receptor peptide<br /> | ||
| - | **[[2gtk]], [[3qt0]], [[5gtp]], [[5gto]], [[5gtn]], [[6jq7]], [[6izm]], [[6ilq]], [[6ijs]], [[6ijr]], [[6icj]], [[5ycp]], [[5ycn]], [[6ktm]], [[6ktn]] - hPPARγ + NCOA1 peptide<br /> | + | **[[2gtk]], [[3qt0]], [[5gtp]], [[5gto]], [[5gtn]], [[6jq7]], [[6izm]], [[6ilq]], [[6ijs]], [[6ijr]], [[6icj]], [[5ycp]], [[5ycn]], [[6ktm]], [[7cxf]] - hPPARγ + NCOA1 peptide<br /> |
| + | **[[6t1v]], [[7cxg]], [[7cxh]], [[7cxi]], [[7cxj]], [[7cxk]], [[7cxl]] - hPPARγ (mutant) + NCOA1 peptide<br /> | ||
| + | **[[6ktn]] - hPPARγ (mutant) + NCOA1 peptide + leukemia drug<br /> | ||
**[[3cs8]], [[3u9q]]- hPPARγ + PGC-1A peptide<br /> | **[[3cs8]], [[3u9q]]- hPPARγ + PGC-1A peptide<br /> | ||
**[[3cwd]] - hPPARγ + NCOA1-2 peptide<br /> | **[[3cwd]] - hPPARγ + NCOA1-2 peptide<br /> | ||
| - | **[[5two]], [[6izn | + | **[[5two]], [[6izn]], [[6fzj]], [[6t6b]] - hPPARγ + modulating ligand<br /> |
| - | **[[3fur]], [[3kmg]], [[3v9t]], [[3v9v]], [[3v9y]], [[4f9m]], [[3b1m]], [[3lmp]] - hPPARγ + SRC-1 peptide + modulator<br /> | + | **[[3fur]], [[3kmg]], [[3v9t]], [[3v9v]], [[3v9y]], [[4f9m]], [[3b1m]], [[3lmp]], [[6fzp]] - hPPARγ + SRC-1 peptide + modulator<br /> |
| + | **[[6fzf]] - hPPARγ (mutant) + NCOA1+ modulator<br /> | ||
**[[4fgy]], [[2prg]] - hPPARγ + antidiabetic drug + NCOA1 peptide<br /> | **[[4fgy]], [[2prg]] - hPPARγ + antidiabetic drug + NCOA1 peptide<br /> | ||
**[[6oni]], [[6pdz]] - hPPARγ + agonist + NCOR peptide<br /> | **[[6oni]], [[6pdz]] - hPPARγ + agonist + NCOR peptide<br /> | ||
**[[6ad9]] - hPPARγ + anticancer agent + NCOA1 peptide<br /> | **[[6ad9]] - hPPARγ + anticancer agent + NCOA1 peptide<br /> | ||
| + | **[[6izm]], [[6izn]] - hPPARγ + pyridine derivative + NCOA1 peptide<br /> | ||
**[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ + NCOA1 peptide + partial agonist<br /> | **[[3s9s]], [[3t03]], [[2fvj]]- hPPARγ + NCOA1 peptide + partial agonist<br /> | ||
**[[4y29]], [[2fvj]], [[5azt]] - hPPARγ + NCOA1 peptide + ligand<br /> | **[[4y29]], [[2fvj]], [[5azt]] - hPPARγ + NCOA1 peptide + ligand<br /> | ||
| Line 67: | Line 80: | ||
**[[1fm6]] - hPPARγ + antidiabetic drug + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br /> | **[[1fm6]] - hPPARγ + antidiabetic drug + retinoic acid receptor α + NCOA2 peptide + retinoic acid<br /> | ||
**[[3vn2]], [[4hee]], [[4prg]] - hPPARγ + NCOA1 peptide + activator<br /> | **[[3vn2]], [[4hee]], [[4prg]] - hPPARγ + NCOA1 peptide + activator<br /> | ||
| - | **[[6ms7]] - hPPARγ + PGC1 LXXLL<br /> | + | **[[6ms7]] - hPPARγ + PGC1 LXXLL + modulator<br /> |
**[[6dgp]], [[5z6s]], [[5z5s]] - hPPARγ + coactivator peptide<br /> | **[[6dgp]], [[5z6s]], [[5z5s]] - hPPARγ + coactivator peptide<br /> | ||
**[[6d94]] - hPPARγ + mediator of RNA polymerase II peptide<br /> | **[[6d94]] - hPPARγ + mediator of RNA polymerase II peptide<br /> | ||
Revision as of 09:52, 9 December 2021
3D Structures of PPAR
Updated on 09-December-2021
